Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label
tabling member	label

Search

867044

	registered interest
	date	19/03/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Pharmaceutical Price Regulation Scheme
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what progress his Department has made on negotiating a new Pharmaceutical Price Regulation Scheme.
	tabling member constituency	Stafford
	tabling member printed	Jeremy Lefroy
	uin	133162
	answer	answer is ministerial correction date of answer 27/03/2018 answer text <p>Informal discussions have already begun with industry regarding future medicines pricing arrangements. Formal negotiations will begin during 2018.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 27/03/2018 11:48:24 answering member 4067 label Biography information for Steve Brine
	tabling member	4109 label Biography information for Jeremy Lefroy

873628

	registered interest
	date	28/03/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Spondyloarthritis
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure the monitoring of individual Quality Statement measures in the NICE Quality Standard on Spondyloarthritis, to be published in June 2018.
	tabling member constituency	Stafford
	tabling member printed	Jeremy Lefroy
	uin	134742
	answer	answer is ministerial correction date of answer 17/04/2018 answer text <p>The National Institute for Health and Care Excellence (NICE) quality standards are concise sets of statements designed to drive quality improvements within a particular area of care and cover the National Health Service, public health and social care. They are derived from the best available evidence, normally NICE guidance but also other sources of NICE-accredited guidance, and are developed by NICE in collaboration with health and social care professionals, their partners and service users. The Department does not have any arrangements for monitoring the uptake of NICE quality standards centrally as they are not mandatory, although health and care commissioners are expected to take them fully into account.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 17/04/2018 14:04:58 answering member 4067 label Biography information for Steve Brine
	tabling member	4109 label Biography information for Jeremy Lefroy

873629

	registered interest
	date	28/03/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Arthritis
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what the timetable is for the publication of the Rheumatoid and Early Inflammatory Arthritis Annual Report; and whether that report will include additional data collection for spondyloarthritis patients.
	tabling member constituency	Stafford
	tabling member printed	Jeremy Lefroy
	uin	134743
	answer	answer is ministerial correction date of answer 17/04/2018 answer text <p>In August 2017, a new three year Rheumatoid and Early Inflammatory Arthritis Audit was commissioned by the Healthcare Quality Improvement Partnership (HQIP). HQIP manages the National Clinical Audit and Patient Outcomes Programme on behalf of NHS England.</p><p> </p><p>The British Society for Rheumatology was awarded the contract to run the audit, which will assess the care provided by rheumatology services in England and Wales, and the health outcomes this achieves for people living with inflammatory arthritis conditions, including rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis.</p><p> </p><p>Building on the previous audit, which ran from 2014-16, it will provide more focused and precise data and employ real-time feedback to support local quality improvement. The audit is expected to launch in May this year, with first reports expected in the autumn of 2019. More information can be found at the following link:</p><p> </p><p><a href="http://www.rheumatology.org.uk/Knowledge/Excellence/Audits" target="_blank">www.rheumatology.org.uk/Knowledge/Excellence/Audits</a></p> answering member constituency Winchester answering member printed Steve Brine question first answered 17/04/2018 13:59:58 answering member 4067 label Biography information for Steve Brine
	tabling member	4109 label Biography information for Jeremy Lefroy

882155

	registered interest
	date	13/04/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Pharmaceutical Price Regulation Scheme
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what the timetable for negotiations on the new pharmaceutical price regulation scheme is; and if he will make a statement.
	tabling member constituency	Stafford
	tabling member printed	Jeremy Lefroy
	uin	135214
	answer	answer is ministerial correction date of answer 19/04/2018 answer text <p>Informal discussions have already begun with industry regarding future medicines pricing arrangements. Formal negotiations will begin shortly.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 19/04/2018 11:28:11 answering member 4067 label Biography information for Steve Brine
	tabling member	4109 label Biography information for Jeremy Lefroy

964649

	registered interest
	date	03/09/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Medical Treatments: Innovation
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what progress his Department has made on establishing an Accelerated Access Collaborative to manage the new accelerated access pathway.
	tabling member constituency	Stafford
	tabling member printed	Jeremy Lefroy
	uin	169360
	answer	answer is ministerial correction date of answer 11/09/2018 answer text <p>The Accelerated Access Collaborative (AAC) has been successfully established, meeting for the first time in January 2018 and agreeing terms of reference and ways of working. Lord Darzi is the new chair of the AAC, replacing Sir Andrew Witty, who stood down to avoid any conflict of interest with his new role as CEO of Optum. We expect that the Accelerated Access Pathway will launch at the next meeting of the AAC, which will be in the autumn.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 11/09/2018 14:37:19 answering member 4067 label Biography information for Steve Brine
	tabling member	4109 label Biography information for Jeremy Lefroy

964650

	registered interest
	date	03/09/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Medical Treatments: Innovation
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, when the accelerated access pathway is planned to begin designating breakthrough products.
	tabling member constituency	Stafford
	tabling member printed	Jeremy Lefroy
	uin	169361
	answer	answer is ministerial correction date of answer 11/09/2018 answer text <p>The Accelerated Access Collaborative will meet this autumn to launch the Accelerated Access Pathway and the first group of products will be part of their discussions.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 11/09/2018 14:35:39 answering member 4067 label Biography information for Steve Brine
	tabling member	4109 label Biography information for Jeremy Lefroy